Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Chauhan, Mohit
Bestha, Durga Prasad
and
Madaan, Vishal
2010.
Lisdexamfetamine: Stimulant Prodrug for ADHD in Children and Adults.
Clinical Medicine Insights: Therapeutics,
Vol. 2,
Issue. ,
p.
CMT.S1077.
Mattingly, Gregory
2010.
Lisdexamfetamine Dimesylate: A Prodrug Stimulant for the Treatment of ADHD in Children and Adults.
CNS Spectrums,
Vol. 15,
Issue. 5,
p.
315.
Brown, Thomas E.
Brams, Matthew
Gao, Joseph
Gasior, Maria
and
Childress, Ann
2010.
Open-Label Administration of Lisdexamfetamine Dimesylate Improves Executive Function Impairments and Symptoms of Attention-Deficit/Hyperactivity Disorder in Adults.
Postgraduate Medicine,
Vol. 122,
Issue. 5,
p.
7.
Dew, Rachel E
and
Kollins, Scott H
2010.
Lisdexamfetamine dimesylate: a new option in stimulant treatment for ADHD.
Expert Opinion on Pharmacotherapy,
Vol. 11,
Issue. 17,
p.
2907.
Wilens, Timothy E
Morrison, Nicholas R
and
Prince, Jefferson
2011.
An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults.
Expert Review of Neurotherapeutics,
Vol. 11,
Issue. 10,
p.
1443.
Marchant, Barrie K.
Reimherr, Fred W.
Halls, Corinne
Williams, Erika D.
Strong, Robert E.
Kondo, Douglas
Soni, Poonam
and
Robison, Reid J.
2011.
Long-term open-label response to atomoxetine in adult ADHD: influence of sex, emotional dysregulation, and double-blind response to atomoxetine.
ADHD Attention Deficit and Hyperactivity Disorders,
Vol. 3,
Issue. 3,
p.
237.
Brown, Thomas E.
Brams, Matthew
Gasior, Maria
Adeyi, Ben
Babcock, Thomas
Dirks, Bryan
Scheckner, Brian
and
Wigal, Timothy
2011.
Clinical utility of ADHD symptom thresholds to assess normalization of executive function with lisdexamfetamine dimesylate treatment in adults.
Current Medical Research and Opinion,
Vol. 27,
Issue. sup2,
p.
23.
Geissler, Julia
and
Lesch, Klaus-Peter
2011.
A lifetime of attention-deficit/hyperactivity disorder: diagnostic challenges, treatment and neurobiological mechanisms.
Expert Review of Neurotherapeutics,
Vol. 11,
Issue. 10,
p.
1467.
2011.
Learning and Attention Disorders in Adolescence and Adulthood.
p.
489.
Santosh, Paramala J.
Sattar, Sanjida
and
Canagaratnam, Myooran
2011.
Efficacy and Tolerability of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder in Adults.
CNS Drugs,
Vol. 25,
Issue. 9,
p.
737.
Findling, Robert L.
Childress, Ann C.
Cutler, Andrew J.
Gasior, Maria
Hamdani, Mohamed
Ferreira-Cornwell, M. Celeste
and
Squires, Liza
2011.
Efficacy and Safety of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
Journal of the American Academy of Child & Adolescent Psychiatry,
Vol. 50,
Issue. 4,
p.
395.
Bigler, Erin D.
and
Petrie, Jo Ann
2011.
Encyclopedia of Clinical Neuropsychology.
p.
1621.
Ginsberg, Lawrence
Katic, Alain
Adeyi, Ben
Dirks, Bryan
Babcock, Thomas
Lasser, Robert
Scheckner, Brian
and
Adler, Lenard A.
2011.
Long-term treatment outcomes with lisdexamfetamine dimesylate for adults with attention-deficit/hyperactivity disorder stratified by baseline severity.
Current Medical Research and Opinion,
Vol. 27,
Issue. 6,
p.
1097.
Babcock, Thomas
Dirks, Bryan
Adeyi, Ben
and
Scheckner, Brian
2012.
Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration study.
BMC Pharmacology and Toxicology,
Vol. 13,
Issue. 1,
Buitelaar, Jan K.
Trott, Götz-Erik
Hofecker, Maria
Waechter, Sandra
Berwaerts, Joris
Dejonkheere, Joachim
and
Schäuble, Barbara
2012.
Long-term efficacy and safety outcomes with OROS-MPH in adults with ADHD.
The International Journal of Neuropsychopharmacology,
Vol. 15,
Issue. 01,
p.
1.
Childress, Ann C
and
Sallee, Floyd R
2012.
The use of lisdexamfetamine dimesylate for the treatment of ADHD.
Expert Review of Neurotherapeutics,
Vol. 12,
Issue. 1,
p.
13.
Steer, Christopher
Froelich, Jan
Soutullo, César A.
Johnson, Mats
and
Shaw, Monica
2012.
Lisdexamfetamine Dimesylate.
CNS Drugs,
Vol. 26,
Issue. 8,
p.
691.
Ermer, James C.
Haffey, Mary B.
Doll, Walter J.
Martin, Patrick
Sandefer, Erik P.
Dennis, Kerry
Corcoran, Mary
Trespidi, Laura
and
Page, Richard C.
2012.
Pharmacokinetics of Lisdexamfetamine Dimesylate after Targeted Gastrointestinal Release or Oral Administration in Healthy Adults.
Drug Metabolism and Disposition,
Vol. 40,
Issue. 2,
p.
290.
Heal, David J
Smith, Sharon L
Gosden, Jane
and
Nutt, David J
2013.
Amphetamine, past and present – a pharmacological and clinical perspective.
Journal of Psychopharmacology,
Vol. 27,
Issue. 6,
p.
479.
Pennick, Michael
2013.
Metabolism of the prodrug lisdexamfetamine dimesylate in human red blood cells from normal and sickle cell disease donors.
Journal of Drug Assessment,
Vol. 2,
Issue. 1,
p.
17.